Literature DB >> 22526825

Obsessive--compulsive disorder: prevalence, correlates, help-seeking and quality of life in a multiracial Asian population.

Mythily Subramaniam1, Edimansyah Abdin, Janhavi Ajit Vaingankar, Siow Ann Chong.   

Abstract

PURPOSE: Obsessive-compulsive disorder (OCD) is a particularly debilitating disorder characterized by early onset, chronic course, and significant comorbidity. People with OCD often delay or are unwilling to seek treatment. The aim of the study was to establish the prevalence and correlates of obsessive compulsive disorder in the Singapore population, to determine types of obsessive compulsive (O/C) symptoms, the comorbidity of the disorder and to examine the quality of life among those with OCD.
METHODS: The Singapore Mental Health Study was a cross-sectional epidemiological survey of the adult, resident Singapore population. Face-to-face interviews were completed with 6,616 respondents between December 2009 and December 2010 giving a survey response rate of 75.9 %. The diagnoses of lifetime and 12-month mental disorders were established using Version 3.0 of the Composite International Diagnostic Interview (CIDI-3.0); clinical severity of cases in past 12-months was assessed using a fully structured version of the Yale-Brown Obsessive-Compulsive Scale and functional impairment was assessed by using the disease specific Sheehan Disability Scale, which are incorporated in the CIDI. Health-related quality of life was measured using the Euro-Quality of Life Scale.
RESULTS: The lifetime and 12-month prevalence of OCD was 3.0 and 1.1 %, respectively. Younger age and marital status (divorced or separated) were significantly associated with OCD. About 40 % of respondents with lifetime OCD met criteria for other lifetime mental disorders, while 51.6 % of respondents with lifetime OCD had a comorbid physical disorder. The mean score of EQ-Index (0.89) and EQ-VAS (75.58) were lowest in OCD cases as compared with those with any other mental or physical disorders. The proportion of those with lifetime OCD who had sought treatment was 10.2 %.
CONCLUSIONS: While OCD is not an extremely prevalent disorder, it has a profound impact on quality of life and daily activities of those suffering from the disorder. The large treatment gap among those with OCD and the significant delay in seeking treatment after the onset of the illness makes OCD a disorder of significant public health priority.

Entities:  

Mesh:

Year:  2012        PMID: 22526825     DOI: 10.1007/s00127-012-0507-8

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  25 in total

1.  The Singapore Mental Health Study: an overview of the methodology.

Authors:  Mythily Subramaniam; Janhavi Vaingankar; Derrick Heng; Kian Woon Kwok; Yee Wei Lim; Mabel Yap; Siow Ann Chong
Journal:  Int J Methods Psychiatr Res       Date:  2012-02-13       Impact factor: 4.035

Review 2.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

3.  Follow-up studies in obsessional neurosis.

Authors:  D W Goodwin; S B Guze; E Robins
Journal:  Arch Gen Psychiatry       Date:  1969-02

4.  Quality of life in obsessive-compulsive disorder before and after treatment.

Authors:  Steffen Moritz; Michael Rufer; Susanne Fricke; Anne Karow; Matthias Morfeld; Lena Jelinek; Dirk Jacobsen
Journal:  Compr Psychiatry       Date:  2005 Nov-Dec       Impact factor: 3.735

5.  The changing prevalence and severity of obsessive-compulsive disorder criteria from DSM-III to DSM-IV.

Authors:  Rocco Crino; Tim Slade; Gavin Andrews
Journal:  Am J Psychiatry       Date:  2005-05       Impact factor: 18.112

6.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

7.  Obsessive-compulsive disorder: prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000.

Authors:  Albina R Torres; Martin J Prince; Paul E Bebbington; Dinesh Bhugra; Traolach S Brugha; Michael Farrell; Rachel Jenkins; Glyn Lewis; Howard Meltzer; Nicola Singleton
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

8.  To seek advice or not to seek advice about the problem: the help-seeking dilemma for obsessive-compulsive disorder.

Authors:  Amparo Belloch; Gema Del Valle; Carmen Morillo; Carmen Carrió; Elena Cabedo
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-07-31       Impact factor: 4.328

9.  Pathways to the doctor-from person to patient.

Authors:  I K Zola
Journal:  Soc Sci Med       Date:  1973-09       Impact factor: 4.634

10.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

Authors:  W K Goodman; L H Price; S A Rasmussen; C Mazure; R L Fleischmann; C L Hill; G R Heninger; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1989-11
View more
  29 in total

Review 1.  Quality of life in obsessive-compulsive disorder: impact of the disorder and of treatment.

Authors:  Mythily Subramaniam; Pauline Soh; Janhavi Ajit Vaingankar; Louisa Picco; Siow Ann Chong
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

Review 2.  Managing obsessive compulsive disorder.

Authors:  Vlasios Brakoulias
Journal:  Aust Prescr       Date:  2015-08-03

3.  The Role of Religiosity and Guilt in Symptomatology and Outcome of Obsessive Compulsive Disorder.

Authors:  Kumar Rakesh; Sharma Arvind; Bansal Pir Dutt; Bahetra Mamta; Saini Bhavneesh; Moria Kavita; Kaur Navneet; Gupta Shrutika; Bansal Priyanka; Kumar Arun; Kaur Harkamal; Kaur Jagdeep
Journal:  Psychopharmacol Bull       Date:  2021-06-01

Review 4.  Patient-reported outcomes in obsessive-compulsive disorder.

Authors:  Mythily Subramaniam; Pauline Soh; Clarissa Ong; Lee Seng Esmond Seow; Louisa Picco; Janhavi Ajit Vaingankar; Siow Ann Chong
Journal:  Dialogues Clin Neurosci       Date:  2014-06       Impact factor: 5.986

5.  Recognition of mental disorders among a multiracial population in Southeast Asia.

Authors:  Siow Ann Chong; Edimansyah Abdin; Louisa Picco; Shirlene Pang; Anitha Jeyagurunathan; Janhavi Ajit Vaingankar; Kian Woon Kwok; Mythily Subramaniam
Journal:  BMC Psychiatry       Date:  2016-05-04       Impact factor: 3.630

6.  A study of diagnostic accuracy of the Florida Obsessive-Compulsive Inventory--Thai Version (FOCI-T).

Authors:  Ratana Saipanish; Thanita Hiranyatheb; Sudawan Jullagate; Manote Lotrakul
Journal:  BMC Psychiatry       Date:  2015-10-14       Impact factor: 3.630

7.  Cannabis Use in People With Obsessive-Compulsive Symptomatology: Results From a Mexican Epidemiological Sample.

Authors:  Humberto Nicolini; José Jaime Martínez-Magaña; Alma Delia Genis-Mendoza; Jorge Ameth Villatoro Velázquez; Beatriz Camarena; Clara Fleiz Bautista; Marycarmen Bustos-Gamiño; Alejandro Aguilar García; Nuria Lanzagorta; María Elena Medina-Mora
Journal:  Front Psychiatry       Date:  2021-05-10       Impact factor: 4.157

8.  Teachers' Knowledge and Stigmatizing Attitudes Associated With Obsessive-Compulsive Disorder: Effectiveness of a Brief Educational Intervention.

Authors:  Antonio Chaves; Sandra Arnáez; María Roncero; Gemma García-Soriano
Journal:  Front Psychiatry       Date:  2021-06-02       Impact factor: 4.157

9.  The impact of the coronavirus (COVID-19) pandemic on the development of obsessive-compulsive symptoms in Saudi Arabia.

Authors:  Deemah A Alateeq; Haneen N Almughera; Tharaa N Almughera; Raghad F Alfedeah; Taeef S Nasser; Khozama A Alaraj
Journal:  Saudi Med J       Date:  2021-07       Impact factor: 1.422

10.  Retrospective observation of mental disorders during postpartum period: Results from the Singapore mental health study.

Authors:  Vathsala Sagayadevan; Siau Pheng Lee; Edimansyah Abdin; Janhavi Vaingankar; Helen Chen; Siow Ann Chong; Mythily Subramaniam
Journal:  BMC Womens Health       Date:  2015-12-16       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.